Direct antiviral agents against hepatitis C virus: Beneficial or harmful?

Affiliations

¹ Department of Hepatology, Hospital General Universitario de Alicante, Spain. Electronic address: omp_89@hotmail.com.
² Department of Hepatology, Hospital General Universitario de Alicante, Spain.
³ Department of Hepatology, Hospital Marina Baixa, Villajoyosa, Spain.
⁴ Department of Hepatology, Hospital Vinalopó, Elche, Spain.
⁵ Department of Hepatology, Hospital San Juan de Alicante, Spain.
⁶ Department of Hepatology, Hospital General de Torrevieja, Spain.

Comment

Óscar Murcia et al. J Hepatol. 2018 Apr.

. 2018 Apr;68(4):844-845.

doi: 10.1016/j.jhep.2017.10.026. Epub 2017 Nov 1.

¹ Department of Hepatology, Hospital General Universitario de Alicante, Spain. Electronic address: omp_89@hotmail.com.
² Department of Hepatology, Hospital General Universitario de Alicante, Spain.
³ Department of Hepatology, Hospital Marina Baixa, Villajoyosa, Spain.
⁴ Department of Hepatology, Hospital Vinalopó, Elche, Spain.
⁵ Department of Hepatology, Hospital San Juan de Alicante, Spain.
⁶ Department of Hepatology, Hospital General de Torrevieja, Spain.

No abstract available

Keywords: Direct antiviral agent; Hepatitis C virus; Hepatocellular carcinoma; Treatment.

Comment on

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy.
Reig M, Mariño Z, Perelló C, Iñarrairaegui M, Ribeiro A, Lens S, Díaz A, Vilana R, Darnell A, Varela M, Sangro B, Calleja JL, Forns X, Bruix J. Reig M, et al. J Hepatol. 2016 Oct;65(4):719-726. doi: 10.1016/j.jhep.2016.04.008. Epub 2016 Apr 13. J Hepatol. 2016. PMID: 27084592